<?xml version="1.0" encoding="ISO-8859-1"?>
<JDBOR date="2024-12-03 07:13:39" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
  <Availability> 
    <Licence>
      <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
      <ShortIdentifier>CC-BY-4.0</ShortIdentifier>
      <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
    </Licence>
  </Availability>
  <DisorderList count="6150">
    <Disorder id="17601">
      <OrphaCode>166024</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166024</ExpertLink>
      <Name lang="en">Multiple epiphyseal dysplasia-macrocephaly-facial dysmorphism syndrome</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="2">
        <Prevalence id="8322">
          <Source>11389160[PMID]_9689990[PMID]_ [EXPERT]</Source>
          <PrevalenceType id="23697">
            <Name lang="en">Cases/families</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23718">
            <Name lang="en">Case(s)</Name>
          </PrevalenceQualification>
          <PrevalenceClass/>
          <ValMoy>4.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="8323">
          <Source>ORPHANET_11389160[PMID]_9689990[PMID]</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="2">
      <OrphaCode>58</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=58</ExpertLink>
      <Name lang="en">Alexander disease</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="2">
        <Prevalence id="2">
          <Source>21533827[PMID]_[EXPERT]</Source>
          <PrevalenceType id="23676">
            <Name lang="en">Annual incidence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.037</ValMoy>
          <PrevalenceGeographic id="24621">
            <Name lang="en">Japan</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="3">
          <Source>ORPHANET</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23774">
            <Name lang="en">Unknown</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25965">
            <Name lang="en">Not yet validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="17603">
      <OrphaCode>166032</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166032</ExpertLink>
      <Name lang="en">Multiple epiphyseal dysplasia-miniepiphyses syndrome</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="2">
        <Prevalence id="11632">
          <Source>15523498[PMID]</Source>
          <PrevalenceType id="23697">
            <Name lang="en">Cases/families</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23718">
            <Name lang="en">Case(s)</Name>
          </PrevalenceQualification>
          <PrevalenceClass/>
          <ValMoy>2.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="11633">
          <Source>ORPHANET_15523498[PMID]</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="3">
      <OrphaCode>61</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=61</ExpertLink>
      <Name lang="en">Alpha-mannosidosis</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="7">
        <Prevalence id="4">
          <Source>European Medicines Agency 2005[INST]</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.1</ValMoy>
          <PrevalenceGeographic id="23795">
            <Name lang="en">Europe</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="5">
          <Source>9918480[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.09</ValMoy>
          <PrevalenceGeographic id="23949">
            <Name lang="en">Australia</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="6">
          <Source>7900112[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.13</ValMoy>
          <PrevalenceGeographic id="25006">
            <Name lang="en">Norway</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25965">
            <Name lang="en">Not yet validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="7">
          <Source>10480370[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.09</ValMoy>
          <PrevalenceGeographic id="24936">
            <Name lang="en">Netherlands</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="8">
          <Source>14685153[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.12</ValMoy>
          <PrevalenceGeographic id="25090">
            <Name lang="en">Portugal</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="9">
          <Source>20490927[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.38</ValMoy>
          <PrevalenceGeographic id="24257">
            <Name lang="en">Czech Republic</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="12208">
          <Source>25274184[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.07</ValMoy>
          <PrevalenceGeographic id="25335">
            <Name lang="en">Sweden</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="17602">
      <OrphaCode>166029</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166029</ExpertLink>
      <Name lang="en">Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="2">
        <Prevalence id="11634">
          <Source>15523498[PMID]</Source>
          <PrevalenceType id="23697">
            <Name lang="en">Cases/families</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23718">
            <Name lang="en">Case(s)</Name>
          </PrevalenceQualification>
          <PrevalenceClass/>
          <ValMoy>3.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="11635">
          <Source>ORPHANET_15523498[PMID]</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="17605">
      <OrphaCode>166038</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166038</ExpertLink>
      <Name lang="en">Metaphyseal chondrodysplasia, Kaitila type</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="2">
        <Prevalence id="8326">
          <Source>6979929[PMID]</Source>
          <PrevalenceType id="23697">
            <Name lang="en">Cases/families</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23718">
            <Name lang="en">Case(s)</Name>
          </PrevalenceQualification>
          <PrevalenceClass/>
          <ValMoy>2.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="8327">
          <Source>ORPHANET_6979929[PMID]</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23760">
            <Name lang="en">&lt;1 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="5">
      <OrphaCode>93</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93</ExpertLink>
      <Name lang="en">Aspartylglucosaminuria</Name>
      <DisorderType id="21394">
        <Name lang="en">Disease</Name>
      </DisorderType>
      <DisorderGroup id="36547">
        <Name lang="en">Disorder</Name>
      </DisorderGroup>
      <PrevalenceList count="4">
        <Prevalence id="10">
          <Source>9918480[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.2</ValMoy>
          <PrevalenceGeographic id="23949">
            <Name lang="en">Australia</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="11">
          <Source>ORPHANET</Source>
          <PrevalenceType id="23669">
            <Name lang="en">Point prevalence</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23704">
            <Name lang="en">Class only</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23774">
            <Name lang="en">Unknown</Name>
          </PrevalenceClass>
          <ValMoy>0.0</ValMoy>
          <PrevalenceGeographic id="23844">
            <Name lang="en">Worldwide</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25965">
            <Name lang="en">Not yet validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="12205">
          <Source>25274184[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23739">
            <Name lang="en">1-9 / 1 000 000</Name>
          </PrevalenceClass>
          <ValMoy>0.62</ValMoy>
          <PrevalenceGeographic id="25335">
            <Name lang="en">Sweden</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
        <Prevalence id="13306">
          <Source>27906067[PMID]</Source>
          <PrevalenceType id="23683">
            <Name lang="en">Prevalence at birth</Name>
          </PrevalenceType>
          <PrevalenceQualification id="23711">
            <Name lang="en">Value and class</Name>
          </PrevalenceQualification>
          <PrevalenceClass id="23746">
            <Name lang="en">1-9 / 100 000</Name>
          </PrevalenceClass>
          <ValMoy>3.35</ValMoy>
          <PrevalenceGeographic id="24362">
            <Name lang="en">Finland</Name>
          </PrevalenceGeographic>
          <PrevalenceValidationStatus id="25958">
            <Name lang="en">Validated</Name>
          </PrevalenceValidationStatus>
        </Prevalence>
      </PrevalenceList>
    </Disorder>
    <Disorder id="17604">
      <OrphaCode>166035</OrphaCode>
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166035</ExpertLink>
      <Name lang="en">Brachydactyly-short stature-retinitis pigmentosa syndrome</Name>
      <DisorderType id="21401">
        <Name lang="en">Malformation syndrome</Name>
      </DisorderType>
      <DisorderGroup id="36547">
